Physician profile
Martin Okoth
NPI 1386009165
$1,132.70
in general payments reported to CMS, 2019-2025
13 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.55 · 2022: $209 · 2023: $368 · 2024: $383 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.32 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $149.89 | 2025 | Rexulti |
| Edwards Lifesciences Corporation | $148.78 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bioventus LLC | $122.43 | 2022 | |
| Abbvie INC. | $113.59 | 2023 | |
| Horizon Therapeutics Plc | $105.36 | 2023 | Uplizna |
| Genzyme Corporation | $97.31 | 2024 | |
| Heron Therapeutics, INC. | $86.40 | 2022 | |
| Joint Restoration Foundation, INC. | $82.97 | 2024 | |
| Solventum Corporation | $73.56 | 2024 | Ioban 2, V.A.C.Ulta, Prevena Restor Axioform |
| Neurocrine Biosciences, INC. | $52.31 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $41.63 | 2024 | Airsupra |
| Axsome Therapeutics, INC. | $34.92 | 2024 | Auvelity |
| Stryker Corporation | $23.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Okoth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.